Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 6, 2015, Pages 1065-1074

  Tang, Wei Ping ^a   Akahoshi, Tomohiko ^a,b   Piao, Jing Shu ^a   Narahara, Sayoko ^a   Murata, Masaharu ^a   Kawano, Takahito ^a   Hamano, Nobuhito ^a   Ikeda, Tetsuo ^b   Hashizume, Makoto ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

ADSCs; bFGF; HGF; Liver cirrhosis; RNA interference

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; FIBROBLAST GROWTH FACTOR 2; SCATTER FACTOR; SMALL INTERFERING RNA;

ADIPOSE TISSUE CELL; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DNA SYNTHESIS; EX VIVO STUDY; FLOW CYTOMETRY; GENE SILENCING; IMMUNOFLUORESCENCE; INVESTIGATIVE PROCEDURES; LIVER FUNCTION; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RAT; STELLATE CELL; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; FISCHER 344 RAT; LIVER CIRRHOSIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS);

ADIPOSE TISSUE; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 2; HEPATOCYTE GROWTH FACTOR; LIVER CIRRHOSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; RATS, INBRED F344;

EID: 84928340692     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12893     Document Type: Article

References (37)

1. Seki E, De Minicis S, Osterreicher CH etal. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007; 13: 1324-1332.
2. Hikita H, Takehara T, Kodama T etal. Delayed-onset caspase-dependent massive hepatocyte apoptosis upon Fas activation in Bak/Bax-deficient mice. Hepatology 2011; 54: 240-251.
3. Iwaisako K, Brenner DA, Kisseleva T. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J. Gastroenterol. Hepatol. 2012; 27: 65-68.
4. Kakinuma S, Nakauchi H, Watanabe M. Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease. J. Gastroenterol. 2009; 44: 167-172.
5. Kiyohashi K, Kakinuma S, Kamiya A etal. Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. Hepatology 2013; 57: 2502-2513.
6. Xu L, Gong Y, Wang B etal. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells. J. Gastroenterol. Hepatol. 2014; 29: 1620-1628.
7. Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut 2007; 56: 716-724.
8. Gupta K, Hergrueter A, Owen CA. Adipose-derived stem cells weigh in as novel therapeutics for acute lung injury. Stem Cell Res. Ther. 2013; 4: 19.
9. Zuk PA. The adipose-derived stem cell: looking back and looking ahead. Mol. Biol. Cell 2010; 21: 1783-1787.
10. Schäffler A, Büchler C. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25: 818-827.
11. Banas A, Teratani T, Yamamoto Y etal. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007; 46: 219-228.
12. Dmitrieva RI, Minullina IR, Bilibina AA etal. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle 2012; 11: 377-383.
13. McIntosh K, Zvonic S, Garrett S etal. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006; 24: 1246-1253.
14. Puissant B, Barreau C, Bourin P etal. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br. J. Haematol. 2005; 129: 118-129.
15. Banas A, Teratani T, Yamamoto Y etal. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J. Gastroenterol. Hepatol. 2009; 24: 70-77.
16. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008; 103: 1204-1219.
17. Estes BT, Diekman BO, Gimble JM, Guilak F. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat. Protoc. 2010; 1: 1559-1582.
18. Banas A, Teratani T, Yamamoto Y etal. In vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008; 26: 2705-2712.
19. Vinken M, Maes M, Oliveira AG etal. Primary hepatocytes and their cultures in liver apoptosis research. Arch. Toxicol. 2014; 88: 199-212.
20. Trim JE, Samra SK, Arthur MJ etal. Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. J. Biol. Chem. 2000; 275: 6657-6663.
21. Zaragosi LE, Ailhaud G, Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 2006; 24: 2412-2419.
22. Kwon Y, Smith BD, Zhou Y etal. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene 2015; 34: 144-153. doi:10.1038/onc.2013.539
23. Kim WH, Matsumoto K, Nakamura T etal. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am. J. Pathol. 2005; 166: 1017-1028.
24. Lin CL, Kao JH. Risk stratification for hepatitis B virus related hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2013; 28: 10-17.
25. Thabut D, Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J. Hepatol. 2010; 53: 976-980.
26. Modi AA, Feld JJ, Park Y etal. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010; 51: 201-209.
27. Nakamura T, Sakai K, Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J. Gastroenterol. Hepatol. 2011; 26: 188-202.
28. Flaquer M, Franquesa M, Vidal A etal. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia 2012; 55: 2059-2068.
29. Shiota G, Okano J, Kawasaki H etal. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21: 106-111.
30. Kodama T, Takehara T, Hikita H etal. Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice. Gastroenterology 2010; 138: 2487-2498.
31. Zhu C, Ikemoto T, Utsunomiya T etal. Senescence-related genes possibly responsible for poor liver regeneration after hepatectomy in elderly patients. J. Gastroenterol. Hepatol. 2014; 29: 1102-1108.
32. Oyagi S, Hirose M, Kojima M etal. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J. Hepatol. 2006; 44: 742-748.
33. Nakagami H, Maeda K, Morishita R etal. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 2542-2547.
34. Trim N, Morgan S, Evans M etal. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am. J. Pathol. 2000; 156: 1235-1243.
35. Conner EA, Teramoto T, Wirth PJ etal. HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Carcinogenesis 1999; 20: 583-590.
36. Watson MR, Wallace K, Gieling RG etal. NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J. Hepatol. 2008; 48: 589-597.
37. Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 2010; 12: 87-117.